VPIM
Vanguard Personalized Indexing Management’s Fate Therapeutics FATE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $79.9K | Buy |
71,364
+28,268
| +66% | +$31.7K | ﹤0.01% | 1770 |
|
|
2025
Q1 | $34.1K | Buy |
43,096
+28,324
| +192% | +$22.4K | ﹤0.01% | 1715 |
|
|
2024
Q4 | $24.4K | Buy |
14,772
+821
| +6% | +$1.36K | ﹤0.01% | 1754 |
|
|
2024
Q3 | $48.8K | Sell |
13,951
-826
| -6% | -$2.89K | ﹤0.01% | 1679 |
|
|
2024
Q2 | $48.5K | Buy |
14,777
+1,195
| +9% | +$3.92K | ﹤0.01% | 1587 |
|
|
2024
Q1 | $99.7K | Buy |
13,582
+1,225
| +10% | +$8.99K | ﹤0.01% | 1520 |
|
|
2023
Q4 | $46.2K | Sell |
12,357
-1,997
| -14% | -$7.47K | ﹤0.01% | 1520 |
|
|
2023
Q3 | $30.4K | Buy |
+14,354
| New | +$30.4K | ﹤0.01% | 1431 |
|
|
2022
Q3 | – | Sell |
-10,100
| Closed | -$250K | – | 1251 |
|
|
2022
Q2 | $250K | Sell |
10,100
-334
| -3% | -$8.27K | 0.01% | 1042 |
|
|
2022
Q1 | $405K | Buy |
10,434
+6,402
| +159% | +$248K | 0.02% | 908 |
|
|
2021
Q4 | $236K | Buy |
4,032
+225
| +6% | +$13.2K | 0.01% | 943 |
|
|
2021
Q3 | $226K | Buy |
3,807
+1,326
| +53% | +$78.7K | 0.02% | 886 |
|
|
2021
Q2 | $215K | Buy |
+2,481
| New | +$215K | 0.02% | 869 |
|